Pfizer challenges Novo and Lilly: GLP-1 drug available for pre-order in China

Pfizer challenges Novo and Lilly: GLP-1 drug available for pre-order in China Pfizer’s GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of intensifying competition with rivals in a market analysis expected to be worth billions of…